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Although Deep Brain Stimulation (DBS) is an established treatment for Parkinson's disease (PD), there are
still limitations in terms of effectivity, side-effects and battery consumption. One of the reasons for this
may be that not only pathological but also physiological neural activity can be suppressed whilst
stimulating. For this reason, adaptive DBS (aDBS), where stimulation is applied according to the level of
pathological activity, might be advantageous. Initial studies of aDBS demonstrate effectiveness in PD, but
there are still many questions to be answered before aDBS can be applied clinically. Here we discuss the
feedback signals and stimulation algorithms involved in adaptive stimulation in PD and sketch a po-
tential road-map towards clinical application.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Deep Brain Stimulation (DBS) is one of the most effective
treatments for advanced Parkinson's disease (PD). However,
although it has been applied for over 25 years, there are still limi-
tations in terms of efﬁcacy, side-effects and efﬁciency. At present,
conventional DBS targeted at the subthalamic nucleus (STN) or
globus pallidus interna (GPi) provides, on average, only about 40%
improvement in the motor items of the Uniﬁed Parkinson's Disease
Rating Scale (UPDRS III) OFF dopaminergic medication. Further-
more, there is even evidence that DBS can, paradoxically, worsen
motor functioning by not only inﬂuencing pathological but also
physiological neural activity [1,2]. Next to this, the potential of
conventional DBS is often limited due to stimulation induced side-
effects. Finally, the capacity of non-rechargeable batteries is
limited, and many patients are unsuitable for rechargeable devices.
Thus in some patients battery replacement surgery may need to
take place every few years.
Although there are many stimulation parameters that can be
adjusted, the key attribute of conventional DBS is that stimulation
is delivered continuously, and is thus non-adaptive. In theory, DBS
could work more effectively with less side effects and be more
efﬁcient were it only to stimulate as and when necessary. This typencil Brain Network Dynamics
wn).
r Ltd. This is an open access articleof stimulation is called adaptive DBS (aDBS).
For aDBS to be achieved, it must be subject to feedback control
and adjustments automatised. In PD, there are a variety of mea-
surements that could form the basis for feedback, particularly the
spontaneous electrophysiological activity recorded in the brain,
termed the local ﬁeld potential (LFP), and accelerometer mea-
surements of tremor activity. The requirements of these feedback
signals are partly dictated by the precisemeans of stimulation. High
frequency DBS just requires feedback signals to be indicative of
current clinical state, but not necessarily causally important.
However, as we will discuss, some stimulation patterns under
development require the sensed signal to be causally important, as
stimulation is speciﬁcally tailored to suppress the sensed signal.
2. Potential feedback signals in aDBS according to
impairment in Parkinson's disease
2.1. Bradykinesia and rigidity
At present there is substantial experimental evidence that
elevated beta (13e35 Hz) frequency band power in the STN or
pallidal LFP is associated with bradykinesia and rigidity, but not
tremor, in PD [3]. This beta signal is also robust, remaining
recordable over many years [4]. More recently, functional distinc-
tions have been suggested between beta oscillations in the low
(13e20 Hz) and high (21e35 Hz) beta frequency range. Although
combined magnetoencephalography and STN LFP recordings show
cortical-subcortical coherence in the high beta range [5], STN LFPunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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after the application of dopaminergic medication [6] or in the
correlation with Parkinsonian severity in the untreated state [7]. It
remains unclear whether the power of low or high frequency beta
might serve as the better feedback signal for aDBS.
Besides the power of beta oscillations, the volatility of beta
power might potentially serve as a biomarker as well. The reason
for this is that coefﬁcient of variation (CV) of beta power in the OFF-
state is signiﬁcantly, inversely, correlated with UPDRS III scores and
with the change in UPDRS III scores after the application of dopa-
minergic medication [8]. Another feature of activity in the beta
frequency band that has recently come to the fore is themodulation
of other frequencies of LFP activity by the phase of the beta signal.
This has been noted in several forms. At the level of the motor
cortex phase amplitude coupling (PAC) involves modulation of the
amplitude of cortical broad gamma oscillations (from ~50 to
200 Hz) by the phase of beta oscillations in patients with PD. Such
PAC decreases in relation to movements [9], and is decreased by
DBS, with the degree of reduction correlating with motor
improvement [10]. This cortical PAC has been suggested as another
potential biomarker for aDBS [10].
Another form of PAC has been reported in the STN, and involves
amplitude modulation of LFP activity in the range between 200 and
400 Hz, termed high frequency oscillations (HFO's), by the phase of
STN beta activity [11]. The peak frequency of HFO's changes from
around 250 Hz to about 340 Hz after treatment with dopaminergic
medication, and the strength of HFO PAC correlates with the UPDRS
III score OFF medication. However, it is not yet known which
particular UPDRS III items best correlate and to what extent DBS
inﬂuences HFO PAC, although electrodes that show greater HFO
PAC turn out to be more likely the contacts that are clinically
effective [11].
PAC provides an interesting potential feedback signal for aDBS,
but also one that is challenging to record and analyse on-line,
particularly given the very low amplitude of high frequency activ-
ities. Whether PAC it is more directly informative of clinical state
than beta band power or its variation also remains to be seen. Nor is
the causal relevance of any of these beta related phenomena
established with respect to different Parkinsonian symptoms.
2.2. Tremor
Beta band LFP power does not correlate with tremor. Rather
neural activity at tremor frequency (~5 Hz) and its ﬁrst harmonic
(~10 Hz) has been recorded in the cortico-basal ganglia-cortical
loop in tremulous PD patients and its amplitude suggested as a
possible feedback signal for aDBS [12]. It seems plausible that these
central oscillations at tremor related frequencies might also be
causally related to tremor, particularly as surgical lesioning or
stimulation of key sites at which such oscillations have been
recorded lead to tremor suppression. This opens up the possibility
of aDBS based on phase-interference stimulation techniques (see
below). Tremor is also easily recorded using peripheral acceler-
ometers providing another potential source of feedback with which
to modulate aDBS.
2.3. Dyskinesias
Although DBS generally affords dramatic amelioration of dys-
kinesias in PD, 2e4% of patients experience DBS induced dyskine-
sias. Spectral features in the LFP that have been associated with
dyskinesias are a shift from elevated beta power to increased ac-
tivity in the 4e10 Hz and/or 65e90 Hz ranges [13,14]. Interestingly,
the low-frequency spectral peak is also seen in the LFP power
spectrum of dystonia patients recorded in GPi [15] and stimulationof the STN at 5 Hz has induced involuntary choreiform movements
in PD patients undergoing DBS surgery [16]. In theory such shifts in
LFP frequency could serve to denote dyskinesias, but thesemight be
more faithfully captured and fed back from peripheral inertial
sensors. Alternatively, it might be that by tracking only beta power,
stimulation can be reduced when such power falls low, thereby
avoiding DBS induced dyskinesias.
2.4. Freezing & other axial features
After 10e15 years, it is often not limb bradykinesia-rigidity, but
axial motor features that dominate the motor phenotype of PD.
Contrary to ‘appendicular’ motor signs, axial symptoms respond
less well to STN or pallidal DBS. Lately, the pendunculopontine
nucleus (PPN) has been suggested as a more successful target for
the treatment of gait and balance problems [17]. A recent report
showed decreased 5e12 Hz activation in the PPN when patients
were unable to step because of severe freezing of gait [18].
Conversely, when patients on dopaminergic medication were able
to walk, 5e12 Hz activity increased [19]. Could PPN LFP power over
5e12 Hz form the basis for aDBS in this nucleus? So far, however, no
data have been presented on the modulation of local oscillatory
activity by PPN DBS, and the efﬁcacy of stimulation of this target is
still debated.
3. Stimulation parameters for aDBS
Many stimulation parameters can be used in aDBS. In the aDBS
studies that have been published up to now [20e23], high fre-
quency (~130 Hz) stimulation, with regular pulses with a ﬁxed
inter-pulse interval, were given. There are two different approaches
to the application of high frequency aDBS: a binary approach, with
effective stimulation either on or off, and a scalar approach with
stimulation voltage being varied up to and including therapeutic
values. Care has to be taken with both approaches that stimulation
voltage is not rapidly increased with the induction of paresthesia.
This issue is particularly important with binary on-off stimulation,
where it is managed by the incorporation of a ramping of stimu-
lation onset and offset. With regard to the scalar stimulation
approach, the value of stimulating at sub-threshold voltages re-
mains to be clariﬁed.
Recent ﬁndings suggest an alternative approach to stimulation
when oscillatory activity is believed to be causally important. This
opens up the possibility of aDBS based on phase-interference
stimulation techniques. When the thalamus is stimulated at low
frequencies shocks delivered at certain phases of the peripheral
tremor, and hence presumably of central tremor oscillations, rein-
force peripheral tremor whereas those delivered at other phases
attenuate tremor. By steering aDBS to the latter phases, a very se-
lective form of aDBS treatment could potentially be performed
[24,25]. Support for approaches in which oscillation phase is
detected and then stimulation delivered to optimally disturb or
cancel oscillations comes from two studies. The ﬁrst will be
described in the following section [26]. In the second study, a non-
invasive technique, transcranial alternating current stimulation
(TACS), was able to reduce PD tremor by delivering sinusoidal
varying current at the correct frequency and phase offset to cancel
central tremor oscillations [27].
4. Current experience of aDBS in non-human primates and
patients with Parkinsonism
The ﬁrst experimental evidence of the successful application of
aDBS in Parkinsonism came from non-human primates [26]. In this
landmark study two monkeys were implanted with electrodes in
M. Beudel, P. Brown / Parkinsonism and Related Disorders 22 (2016) S123eS126 S125the GPi and ipsilateral primary motor cortex. The most successful
stimulation regime tested involved detection of single neuron spike
discharges in motor cortex and the subsequent delivery of series of
seven pulses to the GPi at high frequency, after a delay of 80ms. The
delay of 80 ms coincided with the period of spontaneous oscilla-
tions in the BG-cortical loop in this model, and therefore the
approach might be considered a form of phase interference of
pathological oscillators. Bradykinesia improved signiﬁcantly
compared to 130 Hz (continuous) cDBS despite less overall
stimulation.
The results of the ﬁrst patient to be stimulated with aDBS were
brieﬂy reported in 2012 [20], and these authors followed this up
with publication of a detailed series of 8 further patients in 2013
[21]. The approach taken was similar across these reports, and
involved the triggering of unilateral, high frequency STN DBSwhilst
a threshold level of beta activity was exceeded at the stimulation
target. Adaptive DBS was only tested for short periods of about
5 min, and was evaluated through blinded video assessments.
Nevertheless, aDBS proved more effective than conventional
continuous, ipsilateral, high frequency DBS despite stimulating for
less than 50% of the time.
The above is encouraging, but aDBS was only applied unilater-
ally and for brief periods, so that axial signs and gait could not be
assessed. Moreover, DBS-related side effects, such as speech
impairment, are predominantly seen with bilateral stimulation. So
far the effects of bilateral aDBS have been reported in a small series
and in one case report. In the former, STN aDBS was delivered in
four patients bilaterally with independent triggering of stimulation
in the two hemispheres according to the amplitude of beta activity
at the corresponding electrode [23] (Fig. 1). Blinded video assess-
ments of both limb and axial features conﬁrmed a 43% improve-
ment compared to no stimulation, despite an average time on
stimulation of only 45%. Although aDBS was not directly comparedFig. 1. Example of bilateral adaptive DBS (aDBS) based on LFP beta oscillation power in the S
resulting in a left (blue) and right (red) LFP signal. B. After ﬁltering around a patient speciﬁc
traces). When beta power exceeds a threshold, stimulation is delivered (upper two traces
increasing and decreasing voltage to limit stimulation induced paraesthesiae. The stimulat
references to colour in this ﬁgure legend, the reader is referred to the web version of thiswith conventional DBS, the degree of improvement was at least as
good as in other studies where conventional, continuous stimula-
tion was evaluated with blinded video assessments. Levodopa was
well tolerated during aDBS and led to further reductions in the time
on stimulation. The case report of bilateral aDBS is particularly
tantalising as it provides the ﬁrst suggestion that aDBS may reduce
stimulation-induced side-effects given that less energy is delivered
over time [22]. Both aDBS and cDBS improved axial symptoms,
aDBS delivered for over 2 h improved bradykinesia better than
cDBS, and critically dyskinesias were diminished with aDBS in the
ON medication state.
One of the unexpected but consistent features of the above
studies is that aDBS was more effective than conventional DBS in
the same subjects [21,22,26]. This needs to be conﬁrmed further,
but raises the possibility that the beneﬁts of suppressing patho-
logical activity with conventional continuous DBS may be partly
offset by the simultaneous interruption of residual periods of
physiological motor processing [1]. Adaptive DBS, by sparing pe-
riods where the LFP suggests relative normality of functioning, may
paradoxically then lead to improved efﬁcacy.
In conclusion, clinical experience of aDBS in PD is relatively
scant, and conﬁned to the use of simple beta amplitude determined
control of high frequency stimulation voltage and duration.
Although the results are encouraging as proof-of-principle, DBS-
related side-effects like speech and gait impairment remain to be
objectively contrasted between aDBS and conventional DBS, and all
the reports to date involve the testing of patients a few days after
electrode implantation, when in some centres leads are still
accessible before surgery to insert the implantable pulse generator.
Unfortunately this period is confounded by the so-called stun effect
[28], which means that parkinsonian deﬁcits may be temporarily
ameliorated and LFPs potentially unrepresentative of the chronic
state. Although this could potentially be circumvented byTN of both sides. A. LFP's are recorded from the non-stimulating DBS electrode contacts
beta peak, in this case 20 ± 3 Hz, its amplitude can be calculated real-time (lower two
). C. In this example, high frequency (130 Hz) stimulation is provided with gradually
ion across the two sides is discontinuous and independent. (For interpretation of the
article.)
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time available then is short and ultimately aDBS will have to be
trialled using a chronically implanted device.
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